Can mentorship and skills training boost resilience in HIV-Positive teen moms?

NCT ID NCT07807670

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 08, 2026 · Last updated Sep 09, 2026 · Updated 1 time

Summary

This study evaluates a program for HIV-positive adolescent girls and young women who are pregnant or parenting. The program offers education on sexual health, support groups, skills development, mentorship, and involvement of young fathers. Researchers will measure resilience and treatment adherence using surveys and interviews. The goal is to see if this comprehensive support can help these young mothers manage their health and well-being.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
P2G comprehensive package: sexual and reproductive health education, support groups, skills development, mother-baby pairing, mentorship, and young father involvement sessions
What this could lead to
If effective, this program could offer a model to help HIV-positive teen mothers stay healthy and adhere to treatment, improving their well-being and reducing mother-to-child transmission.
What could go wrong
This is an evaluation without a control group, so it cannot prove the program causes improvements. Results may not apply beyond this setting, and the program's many parts make it hard to know which component helps.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

1,257 people

The number who actually took part.

Started

Apr 2020

Finished

Nov 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

10 to 19 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * HIV positive * Adolescent girls \>18 years old * Pregnant or * parenting a baby \<2 years old * Voluntary/informed consent Exclusion Criteria: * HIV Negative * Not pregnant or parenting a child \>2 years old * Unwilling to provide consent * \< 18 years of age * newly recruited in P2G program (less than 6 months exposure to intervention)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for 10-19 years old are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease HIV Seropositivity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Kanyama General Hospital Youth Friendly Space (YFS) Matero General Hospital YFS George Clinic YFS Mandevu Clinic YFS Chilenje Level 1 YFS Chainda Clinic YFS Bauleni clinic YFS Mtendere Clinic YFS Chawama General Hospital YFS Chipata General Hospital YFS

    Lusaka, Lusaka Province, 10101, Zambia

More trials for these conditions

Other studies related to the condition(s) this trial covers.